Earnings History Data for Iovance Biotherapeutics, Inc. (IOVA) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Iovance Biotherapeutics, Inc.

Iovance Biotherapeutics, Inc. is a biopharmaceutical company. It focused on the development and commercialization of cancer immunotherapy products designed to harness the power of a patient's own immune system to eradicate cancer cells. Iovance Biotherapeutics Inc., formerly known as Lion Biotechnologies Inc., is based in SAN CARLOS, United States.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
07-08-2025	AH		IOVA	Iovance Biotherapeutics, Inc.	918.32	-0.33	-0.29	-0.34	Iovance Biotherapeutics GAAP EPS of -$0.33 misses by $0.04, revenue of $60M misses by $7.14M [8/7/2025 4:06 PM]	2.10	-0.54 (-20.64%)	1.93	-0.71 (-26.89%)	1.64 - 12.51	38,549,653	17,290,000	2,700,459
Iovance Biotherapeutics GAAP EPS of -$0.33 misses by $0.04, revenue of $60M misses by $7.14M [8/7/2025 4:06 PM] Iovance outlines $250M–$300M 2025 revenue target as restructuring aims to boost margins and expand Amtagvi adoption [8/8/2025 3:16 AM] Iovance falls after missing Q2 expectation [8/8/2025 3:48 PM] Iovance cuts staff amid slow sales start for TIL cell therapy [2025-08-07 06:02AM] Iovance Biotherapeutics: Q2 Earnings Snapshot [Aug-07-25 04:20PM]
08-05-2025	AH		IOVA	Iovance Biotherapeutics, Inc.	1,020	-0.36	-0.25	-0.42	Iovance Biotherapeutics GAAP EPS of -$0.36 misses by $0.12, revenue of $49.32M [5/8/2025 4:06 PM]	1.75	-1.42 (-44.95%)	2.01	-1.16 (-36.60%)	1.65 - 13.60	102,293,480	11,150,000	5,241,474
Iovance Biotherapeutics GAAP EPS of -$0.36 misses by $0.12, revenue of $49.32M [5/8/2025 4:06 PM] Iovance revises 2025 revenue guidance to $250M-$300M amid ATC expansion [5/8/2025 10:01 PM] Iovance falls after guidance cut, revenue miss [5/9/2025 12:01 PM] Iovance Biotherapeutics Reports Financial Results and Corporate Updates for First Quarter 2025 [2025-05-08 04:01PM]
27-02-2025	AH		IOVA	Iovance Biotherapeutics, Inc.	1,630	-0.26	-0.27	-0.45	Iovance Biotherapeutics GAAP EPS of -$0.26 beats by $0.01, revenue of $73.69M beats by $1.52M [2/27/2025 4:01 PM]	4.25	-1.01 (-19.30%)	3.91	-1.35 (-25.67%)	3.62 - 18.33	44,537,095	8,330,000	3,135,391
Iovance Biotherapeutics GAAP EPS of -$0.26 beats by $0.01, revenue of $73.69M beats by $1.52M [2/27/2025 4:01 PM] Iovance down 18% warning it could be impacted by geopolitical instability, inflation [2/27/2025 6:17 PM] Iovance Biotherapeutics Reports Financial Results and Corporate Updates for Fourth Quarter and Full Year 2024 [2025-02-27 04:01PM]
07-11-2024	AH		IOVA	Iovance Biotherapeutics, Inc.	3,540	-0.28	-0.31	-0.46	Iovance Biotherapeutics GAAP EPS of -$0.28 beats by $0.02, revenue of $58.6M beats by $4.78M [11/7/2024 4:06 PM]	10.60	-1.68 (-13.68%)	10.78	-1.50 (-12.21%)	3.76 - 18.33	25,873,875	6,140,000	320,683
Iovance Biotherapeutics GAAP EPS of -$0.28 beats by $0.02, revenue of $58.6M beats by $4.78M [11/7/2024 4:06 PM] Iovance falls 12% despite Q3 beats; reaffirms 2024 revenue guidance [11/7/2024 5:49 PM] Iovance Biotherapeutics Reports Financial Results and Corporate Updates for Third Quarter and Year to Date 2024 [2024-11-07 04:01PM]
08-08-2024	AH		IOVA	Iovance Biotherapeutics, Inc.	2,170	-0.34	-0.37	-0.47	Iovance Biotherapeutics GAAP EPS of -$0.34 beats by $0.01, revenue of $31.1M beats by $6.54M [8/8/2024 4:13 PM]	9.88	1.93 (24.37%)	9.35	1.41 (17.76%)	3.21 - 18.33	20,484,155	7,350,000	1,421,914
Iovance Biotherapeutics GAAP EPS of -$0.34 beats by $0.01, revenue of $31.1M beats by $6.54M [8/8/2024 4:13 PM] Iovance soars 17% as 2024 and 2025 revenue guidance well above consensus [8/9/2024 9:29 AM]
09-05-2024	AH		IOVA	Iovance Biotherapeutics, Inc.	3,900	-0.42	-0.45	-0.50	Iovance Biotherapeutics reports Q1 results [5/9/2024 4:03 PM]	11.01	-2.44 (-18.18%)	12.99	-0.46 (-3.42%)	3.21 - 18.33	18,216,130	4,350,000	182,427
Iovance Biotherapeutics reports Q1 results [5/9/2024 4:03 PM]
28-02-2024	AH		IOVA	Iovance Biotherapeutics	4,036	-0.45	-0.44	0.00	Iovance Biotherapeutics GAAP EPS of -$0.45 misses by $0.01, revenue of $0.48M misses by $0.92M [2/28/2024 4:15 PM]	15.89	-1.54 (-8.81%)	16.21	-1.22 (-7.00%)	3.21 - 18.33	15,248,054	23,780,000	320,597
Iovance Biotherapeutics GAAP EPS of -$0.45 misses by $0.01, revenue of $0.48M misses by $0.92M [2/28/2024 4:15 PM]
07-11-2023	AH		IOVA	Iovance Biotherapeutics, Inc.	1,040	-0.46	-0.46	-0.63	Iovance Biotherapeutics GAAP EPS of -$0.46 misses by $0.01 [11/7/2023 4:14 PM]	4.17	-0.15 (-3.36%)	4.42	0.10 (2.31%)	3.21 - 9.36	10,401,139	5,280,000	28,052
Iovance Biotherapeutics GAAP EPS of -$0.46 misses by $0.01 [11/7/2023 4:14 PM]
08-08-2023	AH		IOVA	Iovance Biotherapeutics, Inc.	1,630	-0.47	-0.81	-0.63	Iovance Biotherapeutics GAAP EPS of -$0.47 beats by $0.38, revenue of $0.24M [8/8/2023 4:17 PM]	7.58	0.45 (6.23%)	7.20	0.06 (0.84%)	5.28 - 13.32	6,793,353	3,760,000	7,303
Iovance Biotherapeutics GAAP EPS of -$0.47 beats by $0.38, revenue of $0.24M [8/8/2023 4:17 PM]
09-05-2023	AH	4:00 PM ET (May 9)	IOVA	Iovance Biotherapeutics, Inc.	1,520	-0.50	-0.84	-0.58	Iovance Biotherapeutics GAAP EPS of -$0.50 beats by $0.26 [5/9/2023 4:05 PM]	7.67	0.31 (4.21%)	7.50	0.14 (1.90%)	5.28 - 15.65	6,389,581	4,070,000	14,419
Iovance Biotherapeutics GAAP EPS of -$0.50 beats by $0.26 [5/9/2023 4:05 PM]
28-02-2023	AH	4:00 PM ET (Feb 28)	IOVA	Iovance Biotherapeutics, Inc.	1,170	-0.64	-0.64	-0.63	Iovance Biotherapeutics GAAP EPS of -$0.64 in-line [2/28/2023 4:10 PM]	7.29	0.0 (0.00%)	7.47	0.18 (2.47%)	5.42 - 18.73	2,181,962	3,030,000	4,242
Iovance Biotherapeutics GAAP EPS of -$0.64 in-line [2/28/2023 4:10 PM]
03-11-2022	AH	4:00 PM ET (Nov 3)	IOVA	Iovance Biotherapeutics, Inc.	1,480	-0.63	-0.64	-0.55	Iovance Biotherapeutics GAAP EPS of -$0.63 beats by $0.01 [11/3/2022 4:03 PM]	8.88	0.36 (4.16%)	8.53	0.0 (0.00%)	6.18 - 26.13	2,376,946	1,870,000	24,452
Iovance Biotherapeutics GAAP EPS of -$0.63 beats by $0.01 [11/3/2022 4:03 PM] Iovance Biotherapeutics Reports Third Quarter and Year-to-Date 2022 Financial Results and Corporate Updates [Nov-03-22 04:01PM]
04-08-2022	AH	4:00 PM ET (Aug 4)	IOVA	Iovance Biotherapeutics, Inc.	1,850	-0.63	-0.60	-0.53	Iovance Biotherapeutics GAAP EPS of -$0.63 misses by $0.02 [8/4/2022 4:11 PM]	12.18	-0.36 (-2.87%)	12.18	0.0 (0.00%)	6.18 - 27.96	4,089,689	2,320,000	12,387
Iovance Biotherapeutics GAAP EPS of -$0.63 misses by $0.02 [8/4/2022 4:11 PM] Iovance Biotherapeutics falls 6% on Q2 2022 bottom line miss [8/4/2022 7:19 PM] Iovance Biotherapeutics Reports Second Quarter and First Half 2022 Financial Results and Corporate Updates [Aug-04-22 04:01PM]
05-05-2022	AH	4:00 PM ET (May 5)	IOVA	Iovance Biotherapeutics, Inc.	2,580	-0.58	-0.64	-0.51	Iovance Biotherapeutics GAAP EPS of -$0.58 beats by $0.06 [5/5/2022 4:11 PM]	14.46	-0.37 (-2.49%)	14.83	0.0 (0.00%)	12.18 - 30.82	2,345,295	1,740,000	6,435
Iovance Biotherapeutics GAAP EPS of -$0.58 beats by $0.06 [5/5/2022 4:11 PM] Iovance Biotherapeutics Reports First Quarter 2022 Financial Results and Corporate Updates [May-05-22 04:01PM] Iovance (IOVA) Q1 Earnings Beat, Lifileucel BLA on Track [May-06-22 10:45AM]
24-02-2022	AH	4:00 PM ET (Feb 24)	IOVA	Iovance Biotherapeutics, Inc.	2,430	-0.63	-0.56	-0.47	Iovance Biotherapeutics GAAP EPS of -$0.63 misses by $0.07 [2/24/2022 4:21 PM]	15.15	0.30 (2.02%)	0.0	0.0 (0.00%)	13.28 - 40.15	1,278,476	1,590,000	0
Iovance Biotherapeutics GAAP EPS of -$0.63 misses by $0.07 [2/24/2022 4:21 PM] Iovance Biotherapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Corporate Updates [Feb-24-22 04:01PM] Iovance (IOVA) Announces Wider-Than-Anticipated Q4 Loss [Feb-25-22 09:59AM]
04-11-2021	AH	4:00 PM ET (Nov 4)	IOVA	Iovance Biotherapeutics, Inc.	3,840	-0.55	-0.52	-0.40	Iovance Biotherapeutics EPS misses by $0.03 [11/4/2021 4:04 PM]	24.94	0.43 (1.75%)	24.00	-0.51 (-2.08%)	15.88 - 54.21	1,937,565	1,520,000	63,606
Iovance Biotherapeutics EPS misses by $0.03 [11/4/2021 4:04 PM] Iovance Biotherapeutics (IOVA) Sees Hammer Chart Pattern: Time to Buy? [Nov-03-21 07:04AM] Iovance Biotherapeutics Reports Third Quarter and Year-to-Date 2021 Financial Results and Corporate Updates [Nov-04-21 04:01PM] Iovance Biotherapeutics, inc (IOVA) Q3 2021 Earnings Call Transcript [Nov-05-21 12:32AM] Iovance (IOVA) Reports Wider-Than-Anticipated Loss in Q3 [Nov-05-21 07:02AM]
05-08-2021	AH	4:00 PM ET (Aug 5)	IOVA	Iovance Biotherapeutics, Inc.	3,400	-0.53	-0.51	-0.47	Iovance Biotherapeutics EPS misses by $0.02 [8/5/2021 4:22 PM]	23.62	-0.30 (-1.27%)	24.10	0.17 (0.71%)	15.88 - 54.21	2,118,445	1,640,000	20,586
Iovance Biotherapeutics Reports Second Quarter and First Half 2021 Financial Results and Corporate Updates [Aug-05-21 04:01PM] Iovance (IOVA) Q2 Earnings Miss Estimates, Pipeline in Focus [Aug-06-21 09:28AM]
06-05-2021	AH	4:00 PM ET (May 6)	IOVA	Iovance Biotherapeutics, Inc.	4,830	-0.51	-0.48	-0.55	Iovance Biotherapeutics EPS misses by $0.03 [5/6/2021 4:02 PM]	28.52	-0.09 (-0.31%)	28.52	0.0 (0.00%)	24.67 - 54.21	2,565,612	1,970,000	15,062
Iovance Biotherapeutics EPS misses by $0.03 [5/6/2021 4:02 PM] Iovance Biotherapeutics, Inc. to Host Earnings Call [May-06-21 02:45PM] Iovance Biotherapeutics Reports First Quarter 2021 Financial Results and Corporate Updates [May-06-21 04:01PM] Iovance (IOVA) Q1 Earnings Miss Estimates, Pipeline in Focus [May-07-21 08:35AM]
25-02-2021	AH	4:00 PM ET (Feb 25)	IOVA	Iovance Biotherapeutics, Inc.	6,920	-0.47	-0.46	-0.50	Iovance Biotherapeutics EPS misses by $0.03 [2/25/2021 4:05 PM]	37.43	0.92 (2.52%)	36.22	-0.29 (-0.79%)	18.70 - 54.21	2,285,719	1,296,782	3,121
Iovance Biotherapeutics EPS misses by $0.03 [2/25/2021 4:05 PM] Iovance shares close more than 7% down while Q4 2020 results disappoint [2/25/2021 5:36 PM] Iovance (IOVA) Q4 Earnings Miss Estimates, Pipeline in Focus [Feb-26-21 10:13AM] Iovance Biotherapeutics, Inc. to Host Earnings Call [Feb-25-21 02:30PM]
05-11-2020	AH	4:00 PM ET (Nov 5)	IOVA	Iovance Biotherapeutics, Inc.	5,430	-0.40	-0.46	-0.40	Iovance Biotherapeutics EPS beats by $0.06 [11/5/2020 4:20 PM]	40.38	-0.04 (-0.10%)	40.37	-0.05 (-0.12%)	18.70 - 41.60	871,151	972,329	600

06-08-2020	AH	4:00 PM ET (Aug 6)	IOVA	Iovance Biotherapeutics, Inc.	4,550	-0.47	-0.52	-0.38	Iovance Biotherapeutics EPS beats by $0.05 [8/6/2020 4:05 PM]	30.24	-0.91 (-2.92%)	30.98	-0.17 (-0.55%)	17.67 - 41.49	611,606	958,015	1,057

05-05-2020	AH	4:00 PM ET (May 5)	IOVA	Iovance Biotherapeutics, Inc.	4,060	-0.55	-0.53	-0.30	Iovance Biotherapeutics EPS misses by $0.03 [5/5/2020 4:33 PM]	32.66	0.41 (1.27%)	31.25	-1.41 (-4.32%)	10.15 - 39.00	1,668,060	1,802,218	5,319